Matthew J. Goldstein

1.9k total citations
29 papers, 975 citations indexed

About

Matthew J. Goldstein is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Matthew J. Goldstein has authored 29 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Immunology and 6 papers in Surgery. Recurrent topics in Matthew J. Goldstein's work include Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Matthew J. Goldstein is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Matthew J. Goldstein collaborates with scholars based in United States, Norway and Canada. Matthew J. Goldstein's co-authors include Sawsan Youssef, Lawrence Steinman, Ronald Levy, Holbrook E. Kohrt, Martin S. Weber, Scott S. Zamvil, Shannon E. Dunn, Thomas Prod’homme, May Han and Eun Mi Hur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Matthew J. Goldstein

27 papers receiving 962 citations

Peers

Countries citing papers authored by Matthew J. Goldstein

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Goldstein more than expected).

Fields of papers citing papers by Matthew J. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Goldstein. The network helps show where Matthew J. Goldstein may publish in the future.

Co-authorship network of co-authors of Matthew J. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Goldstein. A scholar is included among the top collaborators of Matthew J. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Goldstein. Matthew J. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 3941: TNG908 is an MTAPnull-selective PRMT5 inhibitor that drives tumor regressions in MTAP-deleted xenograft models across multiple histologies 2022 ·Cancer Research ·Kimberly J. Briggs, Kevin M. Cottrell, (unknown), Erik Wilker, (unknown), Charles B. Davis, Minjie Zhang, (unknown), Deepali Gotur, Matthew J. Goldstein, (unknown), Marc S. Rudoltz, Alan Huang, John P. Maxwell	5
2	Abstract 5006: Comprehensive gene expression analysis of the tumor microenvironment in patients with advanced cancer treated with a personalized neoantigen vaccine, NEO-PV-01, in combination with anti-PD1 2019 ·Cancer Research ·Meghan E. Bushway, Ying S. Ting, Rana H. Besada, Tracey Sciuto, (unknown), Julian Scherer, Kristen N. Balogh, (unknown), Jennifer A. Kaplan, Lisa D. Cleary, Melissa A. Moles, S. Church, (unknown), Xing Ren, Richard B. Gaynor, Matthew J. Goldstein, Les Brail, Joel Greshock, Lakshmi Srinivasan	1
3	Abstract CT125: A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer 2018 ·Cancer Research ·Patrick A. Ott, Ramaswamy Govindan, Aung Naing, Terence W. Friedlander, Kim Margolin, W. Marston Linehan, Nina Bhardwaj, Matthew D. Hellmann, Lakshmi Srinivasan, Joel Greshock, Melissa A. Moles, Richard B. Gaynor, Matthew J. Goldstein, Siwen Hu‐Lieskovan	8
4	New Minimally Invasive Technique for Direct Pars Interarticularis Osteosynthesis Using Cortical Screws and Spinous-Process Modular Link 2016 ·Spine ·Matthew J. Goldstein, (unknown), Robert K. Eastlack	13
5	Quantifying Anesthesia Exposure in Growing Rod Treatment for Early Onset Scoliosis 2016 ·Journal of Pediatric Orthopaedics ·Matthew J. Goldstein, Nima Kabirian, Jeff Pawelek, (unknown), Gregory M. Mundis, Burt Yaszay, Peter O. Newton, Behrooz A. Akbarnia	8
6	What Makes a Top Research Medical School? A Call for a New Model to Evaluate Academic Physicians and Medical School Performance 2015 ·Academic Medicine ·Matthew J. Goldstein, Mitchell R. Lunn, Lily Peng	14
7	Motor Evoked Potentials for Femoral Nerve Protection in Transpsoas Lateral Access Surgery of the Spine 2015 ·PubMed ·Jon E. Block, (unknown), (unknown), (unknown), Hargovind DeWal, (unknown), (unknown), Matthew J. Goldstein	17
8	Acute Posttraumatic Catastrophic Failure of a Second-generation, Highly Cross-linked Ultra-high-molecular-weight Polyethylene Patellar Component 2012 ·Orthopedics ·Matthew J. Goldstein, Michael P. Ast, (unknown)	9
9	Malignant Osseous Tumors of the Pediatric Spine 2012 ·Journal of the American Academy of Orthopaedic Surgeons ·Han Jo Kim, Alexander S. McLawhorn, Matthew J. Goldstein, Patrick J. Boland	17
10	Malignant Osseous Tumors of the Pediatric Spine 2012 ·Journal of the American Academy of Orthopaedic Surgeons ·Han Jo Kim, Alexander S. McLawhorn, Matthew J. Goldstein, Patrick J. Boland	16
11	Immunomodulating antibodies and drugs for the treatment of hematological malignancies 2011 ·Cancer and Metastasis Reviews ·Roch Houot, Holbrook E. Kohrt, Matthew J. Goldstein, Ronald Levy	13
12	Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation 2011 ·Blood ·Holbrook E. Kohrt, Antonia Müller, Jeanette Baker, Matthew J. Goldstein, Evan W. Newell, Suparna Dutt, Debra K. Czerwinski, Robert Lowsky, Samuel Strober	10
13	Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment 2011 ·Blood ·Ash A. Alizadeh, Andrew J. Gentles, Alvaro J. Alencar, Chih Long Liu, Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Shuchun Zhao, Yasodha Natkunam, Ranjana H. Advani, Randy D. Gascoyne, Javier Briones, Robert Tibshirani, June H. Myklebust, Sylvia K. Plevritis, Izidore S. Lossos, Ronald Levy	146
14	A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors 2010 ·Blood ·Matthew J. Goldstein, Bindu Varghese, Joshua Brody, Ranjani Rajapaksa, Holbrook E. Kohrt, Debra K. Czerwinski, Shoshana Levy, Ronald Levy	34
15	Noninvasive Prediction of Graft-Verus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation by Gene Expression Profiling 2010 ·Blood ·Holbrook E. Kohrt, Li Li, Ash A. Alizadeh, Matthew J. Goldstein, Samuel Strober, Minnie Sarwal, Robert Lowsky	1
16	Abstract PR5: Prediction of survival in diffuse large B-cell lymphoma based on the expression of two genes integrating tumor and microenvironment 2010 ·Clinical Cancer Research ·Andrew J. Gentles, Ash A. Alizadeh, Alvaro J. Alencar, Holbrook E. Kohrt, Roch Houot, Matthew J. Goldstein, Yasodha Natkunam, Ranjana H. Advani, Randy D. Gascoyne, Javier Briones, Sylvia K. Plevritis, Izidore S. Lossos, Ronald Levy	1
17	Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity 2009 ·Proceedings of the National Academy of Sciences ·Michael Platten, Sawsan Youssef, Eun Mi Hur, Peggy P. Ho, May Han, Tobias V. Lanz, (unknown), Matthew J. Goldstein, R. Bhat, Cedric S. Raine, Raymond A. Sobel, Lawrence Steinman	256
18	Therapeutic Vaccination against Murine Lymphoma by Intratumoral Injection of Recombinant Fowlpox Virus Encoding CD40 Ligand 2007 ·Cancer Research ·Aichun Liu, Alice E. Guardino, (unknown), Matthew J. Goldstein, Dennis Panicali, Ronald Levy	17
19	Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin 2006 ·The Journal of Experimental Medicine ·Shannon E. Dunn, Sawsan Youssef, Matthew J. Goldstein, Thomas Prod’homme, Martin S. Weber, Scott S. Zamvil, Lawrence Steinman	177
20	Weathering the Budgetary Storm. 2003 ·Matthew J. Goldstein	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact